Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1206-1210

  Lidereau, Rosette ^a   Eisinger, François ^b   Champème, Marie Hélène ^a   Noguès, Catherine ^a   Bièche, Ivan ^a   Birnbaum, Daniel ^b,c   Pallud, Claude ^a   Jacquemier, Jocelyne ^b   Sobol, Hagay ^b  

^a Rene Huguenin Hospital   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CANCER SCREENING; CLINICAL PRACTICE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; OVARY CARCINOMA; PRIORITY JOURNAL;

ADULT; BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC SCREENING; HUMANS; MUTATION; PREDICTIVE VALUE OF TESTS;

EID: 0034161926     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ford, D., Easton, D., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D., Weber, B., Lenoir, G., Chang-Claude, J., Sobol, H., Teare, M., Struewing, J., Arason, A., Schemeck, S., Peto, J., Rebbeck, T., Tonin, P., Neuhausen, S., Barkardottir, R., Eyfjord, J., Lynch, H., Ponder, B., Gayther, S., Birch, J., Lindblom, A., Stoppa-Lyonnet, D., Bignon, Y., Borg, A., Hamann, U., Haites, N., Scott, R., Maugard, C., Vasen, H., Seitz, S., Cannon-Albright, L., Scofield, A., Zeleda-Hedman, M., and the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet., 62: 679-689, 1998.
2. Eisinger, F., Julian-Reynier, C., Chabal, F., Luquet, C., Moatti, J. P., and Sobol, H. Acceptable strategies for dealing with hereditary breast/ovarian cancer risk. J. Natl. Cancer Inst., 89: 731, 1997.
3. Shattuck-Eidens, D., Oliphant, A., McLure, M., McBride, C., Gupte, J., Rubano, T., Pruss, D., Tagvitian, S., Teng, D., Adey, N., Staebell, M., et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing. J. Am. Med. Assoc., 278: 1242-1250, 1997.
4. Malone, K., Daling, J., Thompson, J., O'Brien, C., Francisco, L., and Ostrander, E. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. J. Am. Med. Assoc., 279: 922-929, 1998.
5. Claus, E., Schildkraut, J., Iversen, E. J., Berry, D., and Parmigiani, G. Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J. Natl. Cancer Inst., 90, 1824-1829, 1998.
6. Eisinger, F., Noguès, C., Birnbaum, D., Jacquemier, J., and Sobol, H. BRCA1 and medullary breast cancer. J. Am. Med. Assoc., 280: 1227-1228, 1998.
7. Novakovic, B., Golstein, A., and Tucker, M. Validation of familial history of cancer in deceased family members. J. Natl. Cancer Inst., 88: 1492-1493, 1996.
8. Douglas, F., O'Dair, L., Robinson, M., Evans, G., and Lynch, S. The accuracy of diagnoses as reported in families with cancer: a retrospective study. J. Med. Genet., 36: 309-312, 1999.
9. Andersen, A., Southey, M., Somers, G., McKay, M., Armes, J., McCredie, M., Giles, G., Hopper, J., and Venter, D. De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation. Am. J. Hum. Genet., 65: 567-569, 1999.
10. Armes, J., Egan, A. M., Southey, M., McCredie, M., Giles, G., Hopper, J., and Venter, D. The histologic phenotypes of breast carcinoma occuring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations. Cancer (Phila.), 83: 2335-2345, 1998.
11. Fodor, F. H., Weston, A., Bleiweiss, I. J., McCurdy, L. D., Walsh, M. M., Tartter, P. I., Brower, S. T., and Eng, C. M. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am. J. Hum. Genet., 63: 45-51, 1998.
12. Julian-Reynier, C., Eisinger, F., Moatti, J-P., and Sobol, H. French physicians knowledge about hereditay breast/ovarian cancer: The need for continuous vocational training in genetics. Community Genet., in press, 2000.
13. Eisinger, F., Stoppa-Lyonnet, D., Longy, M., Kerangueven, F., Noguchi, T., Bailly, C., Vincent-Salomon, A., Jacquemier, J., Birnbaum, D., and Sobol, H. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res., 56: 471-474, 1996.
14. Marcus, J., Watson, P., Page, D., Narod, S., Lenoir, S., Tonin, P., Linder-Stephenson, L., Conway, T., and Lynch, H. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (Phila.), 77: 697-709, 1996.
15. Johannsson, O., Idvall, I., Anderson, C., Borg, A., Barkardottir, R., Egilson, V., and Olsson, H. Tumor biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer, 33: 362-371, 1997.
16. Eisinger, F., Jacquemier, J., Charpin, C., Stoppa-Lyonnet, D., Bressac-de Paillerets, B., Peyrat, J-P., Longy, M., Guinebretiere, J-M., Sauvan, R., Noguchi, T., Birnbaum, D., and Sobol, H. Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res., 58: 1588-1592, 1998.
17. Eisinger, F., Noguès, C., Birnbaum, D., Jacquemier, J., and Sobol, H. Low frequency of lymph node metastasis in BRCA1-associated breast cancer. Lancet. 351: 1633-1634, 1998.
18. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet, 349: 1505-1510, 1997.
19. Lakhani, S., Jacquemier, J., Sloane, J., Gusterson, B., Anderson T., van de Vijer, M., Farid, L., Venter, D., Antoniou, A., Storfer-Isser, A., Smyth, E., Steel, M., Haites, N., Scott, R., Goldgar, D., Neuhausen, S., Daly, P., Ormiston, W., McManus, R., Scherneck, S., Ponder, B., Ford, D., Peto, J., Stoppa-Lyonnet, D., Bignon, Y., Streuwing, J., Spurr, N., Bishop, D., Klijn, J., Devilee, P., Cornelisse, C., Lasset, C., Lenoir, G., Barkadottir, R., Egilsson, V., Hamman, U., Chang-Claude, J., Sobol, H., Weber, B., Stratton, M., Easton, D., and the Breast Cancer Linkage Consortium. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BACA1 and BRCA2 mutations. J. Natl. Cancer Inst., 90: 1138-1145, 1998.
20. Eisinger, F., Nogues, C., Guinebretiere, J-M., Peyrat, J-P., Bardou, V-J., Noguchi, T., Vennin, P., Sauvan, R., Lidereau, R., Birnbaum, D., Jacquemier, J., and Sobol, H. Novel indications for BRCA1 screening using individual clinical and morphological features. Int. J. Cancer Predict. Oncol., 84: 263-267, 1999
21. Brown, D., Cole, B., and Arrick, B. Re: multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J. Natl. Cancer Inst., 91: 90-91, 1999.
22. Eisinger, F., Jacquemier, J., Charafe-Jauffret, E., Rio, M-C., Birnbaum, D., and Sobol, H. More about: multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J. Natl. Cancer Inst., 91: 1421-1422, 1999.
23. Couch, F., Weber, B., and the Breast Cancer Information Core. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum. Mutat., 8: 8-18, 1996.
24. Stoppa-Lyonnet, D., Laurent-Puig, P., Essioux, L., Pages, S., Ithier, G., Ligot, L., Fourquet, A., Salmon, R., Clough, K., Pouillart, P., The ICBCG, Bonaiti-Pellié, C., and Thomas, G. BRCA1 sequence variations in 160 individuals referred to a breast/ ovarian family cancer clinic. Am. J. Hum. Genet., 60: 1021-1030, 1997.
25. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., Eddington, K., McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Sšderkvist, P., Terry, L., Jhanwar, S., Berchuck, A., Iglehart, J. D., Marks, J., Ballinger, D. G., Barrett, J. C., Skolnick, M. H., Kamb, A., and Wiseman, R. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
26. Merajver, S. D., Pham, T. M., Caduff, R. F., Chen, M., Poy, E. L., Cooney, K. A., Weber, B. L., Collins, F. S., Johnston, C., and Frank, T. S. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet., 9: 439-443, 1995.
27. Langston, A., Malone, K., Thompson, J., Daling, J., and Ostrander, E. BRCA1 mutations in a population-based sample of young women with breast cancer. N. Engl. J. Med., 334: 137-142, 1996.
28. Julian-Reynier, C., Eisinger, F., Vennin, F., Chabal, F., Aurran, Y., Nogues, C., Bignon, Y., Machelard-Roumagnac, M., Maugard-Louboutin, C., Serin, D., Blanc, B., Orsoni, P., and Sobol, H. Attitudes towards cancer predictive testing and transmission of information to the family. J. Med. Genet., 33: 731-736, 1996.
29. Struewing, J., Hartge, P., Wacholder, S., Baker, S., Berlin, M., McAdams, M., Timmerman, M., Brody, L., and Tucker, M. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med., 336: 1401-1408, 1997.
30. Warner, E., Foulkes, W., Goodwin, P., Meschino, W., Blondal, J., Paterson, C., Ozcelik, H., Goss, P., Allingham-Hawkins, D., Hamel, N., Di Prospero, L., Contiga, V., Serruya, C., Klein, M., Moslehi, R., Honeyford, J., Liede, A., Glendon, G., Brunet, J-S., and Narod, S. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J. Natl. Cancer Inst., 91: 1241-1247, 1999.
31. Newman, B., Mu, H., Butler, L., Millikan, R., Moorman, P., and King, M-C. Frequency of breast cancer attribuable to BRCA1 in a population-based series of American women. J. Am. Med. Assoc., 279: 915-921, 1998.
32. Couch, F., De Shano, M., Blackwood, M., Calzone, K., Stopfer, J., Campeau, L., Ganguly, A., Rebbeck, T., and Weber, B. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med., 336: 1409-1415. 1997.